Does USTEKINUMAB Cause Myalgia? 419 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 419 reports of Myalgia have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.5% of all adverse event reports for USTEKINUMAB.
419
Reports of Myalgia with USTEKINUMAB
0.5%
of all USTEKINUMAB reports
5
Deaths
62
Hospitalizations
How Dangerous Is Myalgia From USTEKINUMAB?
Of the 419 reports, 5 (1.2%) resulted in death, 62 (14.8%) required hospitalization, and 5 (1.2%) were considered life-threatening.
Is Myalgia Listed in the Official Label?
Yes, Myalgia is listed as a known adverse reaction in the official FDA drug label for USTEKINUMAB.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Myalgia?
ATORVASTATIN (7,155)
EVOLOCUMAB (5,061)
ROSUVASTATIN (3,958)
SIMVASTATIN (3,919)
ADALIMUMAB (3,134)
DUPILUMAB (3,064)
DENOSUMAB (2,965)
LEVOTHYROXINE (2,467)
CIPROFLOXACIN (2,291)
EZETIMIBE (2,066)
Which USTEKINUMAB Alternatives Have Lower Myalgia Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE